[Monoamines and the regulation of wakefulness. I. Contribution and biochemical interpretation of the polygraphic data].
D001288:Attention / Q000187:drug effects*; D001679:Biogenic Amines / Q000134:cerebrospinal fluid / Q000378:metabolism*; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D001923:Brain Chemistry; D002395:Catecholamines / Q000378:metabolism; D002940:Circadian Rhythm; D004569:Electroencephalography; D006801:Humans; D008996:Monoamine Oxidase Inhibitors; D010300:Parkinson Disease / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D007319:Sleep Initiation and Maintenance Disorders / Q000503:physiopathology; D012893:Sleep Wake Disorders / Q000503:physiopathology; D012895:Sleep, REM; D014851:Wakefulness / Q000187:drug effects*
D001679:Biogenic Amines; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin
Monoamines et régulation de la vigilance. I. Apport et interprétation biochimique des données polygraphiques.